Streetbeat News

Stock Prices

FND

Floor & Decor Holdings' stock price is on the rise following Guggenheim's decision to maintain a Buy rating and increase the price target from $115 to $130.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:27 pm

TREX

Trex Company, Inc. (NYSE:TREX) exceeded Q4 earnings and sales expectations, reporting adjusted earnings of 20 cents per share and quarterly sales of $195.75 million. The company forecasts FY24 net sales between $1.215 billion and $1.235 billion, significantly above estimates. Following the report, Trex shares dropped by 2.1%. Analysts from Truist Securities, Stifel, DA Davidson, and UBS have raised their price targets on Trex, maintaining Buy and Neutral ratings.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 6:19 pm

WYNN

JP Morgan analyst Joseph Greff has maintained an Overweight rating on Wynn Resorts (NASDAQ:WYNN) and increased the price target from $118 to $123.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:16 pm

CI

Investors have shown a mixed sentiment towards Cigna Group (NYSE:CI), with options trading evenly split between bullish and bearish. Uncommon options activity has been detected, indicating potential insider knowledge of forthcoming developments. The options market is focusing on a price range of $280 to $310 for CI, based on recent trading volumes and open interest. Analysts have issued positive ratings for CI, with a consensus target price of $362.8, suggesting optimism about the company's future performance.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:15 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) reported better-than-expected Q4 earnings, beating analyst estimates with earnings of 1 cent per share and quarterly sales of $246.62 million. The company also issued strong guidance for Q1 2024 and FY 2024, expecting to surpass $1 billion in revenue. Following the report, HIMS shares surged 31.9% to $13.52. Analysts from Truist Securities, Piper Sandler, Citigroup, and Guggenheim have subsequently raised their price targets on HIMS.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 6:10 pm

BSY

Bentley Systems' shares dropped following the announcement of Q4 revenue results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:08 pm

ALB

Albemarle's stock price increased following Mizuho's decision to maintain a Neutral rating while raising its price target from $105 to $115.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:07 pm

RCM

Coliseum Capital Management, a major shareholder of R1 RCM Inc (NASDAQ:RCM), believes New Mountain Capital's $13.75/share acquisition offer undervalues R1 RCM. Despite missing Q4 revenue expectations, R1 RCM reported a significant year-over-year revenue increase and a positive GAAP net income, contrasting with the previous year's loss. The company's CEO highlighted achievements and future growth plans, including revenue and EBITDA projections for 2024. RCM shares rose 4% to $14.45.

Portfolio Pulse from Vandana Singh

February 27, 2024 | 6:06 pm

KRYS

Krystal Biotech, Inc. (NASDAQ:KRYS) exceeded Q4 expectations with earnings of 30 cents per share against an expected loss of 39 cents, and sales of $42.14 million over the $28.61 million forecast. The success follows the FDA approval and launch of VYJUVEK for dystrophic epidermolysis bullosa. The company anticipates FY24 R&D and SG&A expenses between $150 million to $175 million. Following the report, KRYS shares rose by 5.3% to $165.35. Guggenheim and Citigroup raised their price targets for KRYS to $175 and $195, respectively.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 6:03 pm

CDNA

CareDx (NASDAQ:CDNA) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.27. Historical data shows that CareDx has previously beaten EPS estimates, leading to significant share price movements. The company's stock has declined 41.31% over the last 52 weeks, trading at $8.92 as of February 26. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:02 pm